Ahmed H, Alabdul Razzak I, Abdulrazzak E, et al. Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Cirrhosis. ASIDE GI. 2026;2(4):1-7. doi:10.71079/ASIDE.GI.072726751